Samsung SPH-M340 User Manual (user Manual) (ver.f5) (English) - Page 83

FDA is working with the U.S. National Toxicology, Health Organization international Electromagnetic

Page 83 highlights

genetically engineered or treated with cancercausing chemicals so as to be pre-disposed to develop cancer in absence of RF exposure. Other studies exposed the animals to RF for up to 22 hours per day. These conditions are not similar to the conditions under which people use wireless phones, so we don't know with certainty what the results of such studies mean for human health. Three large epidemiology studies have been published since December 2000. Between them, the studies investigated any possible association between the use of wireless phones and primary brain cancer, glioma, meningioma, or acoustic neuroma, tumors of the brain or salivary gland, leukemia, or other cancers. None of the studies demonstrated the existence of any harmful health effects from wireless phones RF exposures. However, none of the studies can answer questions about long-term exposures, since the average period of phone use in these studies was around three years. What research is needed to decide whether RF exposure from wireless phones poses a health risk? A combination of laboratory studies and epidemiological studies of people actually using wireless phones would provide some of the data that are needed. Lifetime animal exposure studies could be completed in a few years. However, very large numbers of animals would be needed to provide reliable proof of a cancer promoting effect if one exists. Epidemiological studies can provide data that is directly applicable to human populations, but ten or more years' follow-up may be needed to provide answers about some health effects, such as cancer. This is because the interval between the time of exposure to a cancer-causing agent and the time tumors develop - if they do - may be many, many years. The interpretation of epidemiological studies is hampered by difficulties in measuring actual RF exposure during day-to-day use of wireless phones. Many factors affect this measurement, such as the angle at which the phone is held, or which model of phone is used. What is FDA doing to find out more about the possible health effects of wireless phone RF? FDA is working with the U.S. National Toxicology Program and with groups of investigators around the world to ensure that high priority animal studies are conducted to address important questions about the effects of exposure to radio frequency energy (RF). FDA has been a leading participant in the World Health Organization international Electromagnetic Fields (EMF) Project since its inception in 1996. An influential result of this work has been the development of a detailed agenda of research needs that has driven the establishment of new research programs around the world. The Project has also helped develop a series of public information documents on EMF issues. Health and Safety Information 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106

Health and Safety Information
80
genetically engineered or treated with cancer-
causing chemicals so as to be pre-disposed to
develop cancer in absence of RF exposure. Other
studies exposed the animals to RF for up to 22 hours
per day. These conditions are not similar to the
conditions under which people use wireless phones,
so we don't know with certainty what the results of
such studies mean for human health.
Three large epidemiology studies have been
published since December 2000. Between them, the
studies investigated any possible association
between the use of wireless phones and primary
brain cancer, glioma, meningioma, or acoustic
neuroma, tumors of the brain or salivary gland,
leukemia, or other cancers. None of the studies
demonstrated the existence of any harmful health
effects from wireless phones RF exposures.
However, none of the studies can answer questions
about long-term exposures, since the average period
of phone use in these studies was around three
years.
What research is needed to decide whether
RF exposure from wireless phones poses a
health risk?
A combination of laboratory studies and
epidemiological studies of people actually using
wireless phones would provide some of the data that
are needed. Lifetime animal exposure studies could
be completed in a few years.
However, very large numbers of animals would be
needed to provide reliable proof of a cancer
promoting effect if one exists. Epidemiological
studies can provide data that is directly applicable to
human populations, but ten or more years' follow-up
may be needed to provide answers about some
health effects, such as cancer.
This is because the interval between the time of
exposure to a cancer-causing agent and the time
tumors develop - if they do - may be many, many
years. The interpretation of epidemiological studies is
hampered by difficulties in measuring actual RF
exposure during day-to-day use of wireless phones.
Many factors affect this measurement, such as the
angle at which the phone is held, or which model of
phone is used.
What is FDA doing to find out more about the
possible health effects of wireless phone RF?
FDA is working with the U.S. National Toxicology
Program and with groups of investigators around the
world to ensure that high priority animal studies are
conducted to address important questions about the
effects of exposure to radio frequency energy (RF).
FDA has been a leading participant in the World
Health Organization international Electromagnetic
Fields (EMF) Project since its inception in 1996.
An influential result of this work has been the
development of a detailed agenda of research needs
that has driven the establishment of new research
programs around the world. The Project has also
helped develop a series of public information
documents on EMF issues.